Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRT106 Plus Chemotherapy in Resectable Pancreatic Cancer
NCT06758544Phase 2Recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Mar 2025
- Primary completion
- Sep 2026
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of VRT-106 in pancreatic cancer (PC), sponsored by Guangdong Provincial People's Hospital. Started Mar 2025; status: recruiting.
02
Drugs
VRT-106
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT06758544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06758544.